Bertil Svane

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

Christer Ericsson, Ulf dé Fairé, Lars Grip et al. · The Lancet · 1996 · 424 citations

Thrombosis, Heart Failure, Cardiovascular Disease +10

Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.

Lars Wallentin, Eva Swahn, Frederic Kontny et al. · PubMed · 1999 · 338 citations

Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study

Hui‐Xin Wang, Constanze Leineweber, Richard L. Kirkeeide et al. · Journal of Internal Medicine · 2007 · 171 citations · Full text

Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women

K. R., Murray A. Mittleman, Karin Schenck‐Gustafsson et al. · Circulation · 1997 · 168 citations

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)

Giacomo Ruotolo, Carl-Göran Ericsson, Cristina Tettamanti et al. · Journal of the American College of Cardiology · 1998 · 164 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Dyslipidemia +7